SmartBrief > Health Care > AANP SmartBrief > Pfizer Inc. Profile

Pfizer Inc.

News and overview for Pfizer Inc.

Pfizer reportedly to sell generic drugs in Japan - MarketWatch
MarketWatch | 4 days 9 hours 12 minutes ago
The U.S. company's Japanese unit plans to set up a division on Dec. 1 dedicated to drugs whose patents have expired, Japanese business daily Nikkei reported.


Pfizer Submits New Pediatric Data For Lipitor (Atorvastatin) To The European Medicines Agency (EMEA) [Press Release]
Business Wire | 5 days 1 hour 59 minutes ago
Pfizer Inc (NYSE:PFE) announced it has submitted pediatric data for Lipitor® (atorvastatin) to the European Medicines Agency (EMEA). Pfizer has also developed a new chewable form of Lipitor, including a pediatric-appropriate 5 mg dose, which is part of this submission.


FDA Advisory Committee Finds Data Support the Safety and Effectiveness of Prevnar 13 Vaccine for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children [Press Release]
Business Wire | 4 days 10 hours 50 minutes ago
Pfizer Inc (NYSE:PFE) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee voted 10 to 1 that the data presented support the safety and effectiveness of its 13-valent pneumococcal conjugate candidate vaccine, Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), for the prevention of invasive pneumococcal disease in infants and young children. The Company is seeking an indication for active...


Pfizer reports 26% higher profit, but lower sales - MarketWatch
MarketWatch | 33 days 22 hours 54 minutes ago
The world's largest drug maker posted net income of $2.88 billion, or 43 cents a share, compared with $2.28 billion, or 34 cents a share, for the same quarter in 2008.


Pfizer subsidiary hit with record fine - MarketWatch
MarketWatch | 36 days 17 hours 38 minutes ago
Pfizer previously agreed to pay an additional $1 billion plus interest to settle civil allegations that it "fraudulently promoted and marketed Bextra, as well as three other drugs in its portfolio, Geodon, an anti-psychotic drug, Zyvox, and antibiotic, and Lyrica, and anti-epileptic drug," the Justice Department said.


Pfizer, Merck may feel pressure from generics - MarketWatch
MarketWatch | 38 days 42 minutes ago
This earnings season will also mark the end of an era for the industry titans, as both are in the final phases of major mergers that aimed at refueling their drug pipelines and stoking profits. On Oct. 15, Pfizer is slated to complete its $68 billion takeover of rival Wyeth. Merck is expected to close on its $41 billion acquisition of Schering-Plough Corp. by the end of the quarter.


Merck, Pfizer, J&J lead drug stocks higher - MarketWatch
MarketWatch | 18 days 19 hours 7 minutes ago
Shares of Merck /quotes/comstock/13*!mrk/quotes/nls/mrk (MRK 32.14, +1.47, +4.79%) were up almost 3% to $41.46.


Pfizer and DNDi Advancing International Research Efforts In The Fight Against Neglected Tropical Diseases [Press Release]
Business Wire | 4 days 21 hours 29 minutes ago
Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world. Under the agreement, DNDi will have access to the Pfizer library of novel chemical entities, in order to screen it for compounds that have the potential to be developed into new treatments.


Pfizer gains on results as Biogen Idec retreats - MarketWatch
MarketWatch | 33 days 20 hours 14 minutes ago
Shares of Pfizer /quotes/comstock/13*!pfe/quotes/nls/pfe (PFE 18.20, +0.22, +1.22%) traded up nearly 2% at $18.29.


Drug stocks decline; Pfizer rises on earnings - MarketWatch
MarketWatch | 33 days 20 hours 54 minutes ago
European shares choppy amid earnings, data





 1  2  3  4  5  6  7  8  9 ...   Next >

4590 Results

Sign up for AANP SmartBrief



Designed specifically for nurse practitioners and health care professionals like you, AANP SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important health care issues. Learn more

Company Overview


Company: Pfizer Inc.
Industry: Pharmaceuticals Manufacturers
Website: http://www.pfizer.com

Pfizer pfabricates pfarmaceuticals pfor quite a pfew inpfirmities. The company is the world's largest research-based pharmaceuticals firm. Its best-known products include erectile dysfunction therapy Viagra, pain management drug Celebrex, high-blood-pressure therapy Norvasc, and cholesterol-lowering Lipitor. Pfizer also keeps Fluffy and Fido in mind with its animal health products, including Revolution (antiparasitic). The company markets its pharmaceuticals directly to health care providers and patients; most of its sales are conducted through wholesalers including McKesson and Cardinal Health. Pfizer acquired pharma rival Wyeth in a $68 billion deal in 2009.


Key Numbers

Sales in U.S. Dollars (mil.) 48,296 (2008)
One-year % Growth in Sales -0.3 (2008)
Net Income in U.S. Dollars (mil.) 8,104 (2008)
One-year % Growth in Net Income -0.5 (2008)
Number of Employees 81,800 (2008)
One-year % Growth in Number of Employees -5.5 (2008)
Fiscal Year-End December